Editorial [ Advanced Glycation End Products (AGEs) and their Receptor (RAGE) in Health and Disease Executive Editor: Sho-ichi Yamagishi ]

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|10|939-939

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.10, 2008-04, pp. : 939-939

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products (AGEs) and their Receptor (RAGE) System in Diabetic Retinopathy

By  

Current Drug Discovery Technologies, Vol. 3, Iss. 1, 2006-03 ,pp. : 83-88

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System

By  

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1135-1141

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 969-972

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 973-978

Bentham Science Publishers

Access to resources Recommend Favorite

Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in Diabetes

By  

Current Drug Targets, Vol. 8, Iss. 10, 2007-10 ,pp. : 1138-1143

Bentham Science Publishers

Access to resources Recommend Favorite